<i>DNMT3A</i> Mutational Status Affects the Results of Dose-Escalated Induction Therapy in Acute Myelogenous Leukemia
Alison R. Sehgal(UPMC Hillman Cancer Center), Martin Carroll(University of Pennsylvania), Selina M. Luger(University of Pennsylvania), Jennifer D. Morrissette(Hospital of the University of Pennsylvania), Robert Daber(University of Pennsylvania), Alison W. Loren(University of Pennsylvania), Jianhua Zhao(Southwest Petroleum University), Jingmei Hsu(Cancer Research Institute), Phyllis A. Gimotty(University of Pennsylvania)
Cited by 55
Related Papers
Final Version of 2009 AJCC Melanoma Staging and Classification
|Journal of Clinical Oncology|2009|4.6k
Prognostic Relevance of Integrated Genetic Profiling in Acute Myeloid Leukemia
|New England Journal of Medicine|2012|1.9k
Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice
|Science|2018|1.5k
Anthracycline Dose Intensification in Acute Myeloid Leukemia
|New England Journal of Medicine|2009|907